Hikma Pharmaceuticals PLC’s (HIK) 20-Day exponential moving average is 1931.72, while Hikma Pharmaceuticals PLC’s (HIK) share price is 1,952p, making it a Buy.

Hikma Pharmaceuticals PLC’s (HIK) 50-Day exponential moving average is 1918.91, while Hikma Pharmaceuticals PLC’s (HIK) share price is 1,952p, making it a Buy.

Advanced Chart >

Hikma Pharmaceuticals (HIK) Pivot Points

Dec 22, 2024, 06:19 AM

Classic

1,891.67

1,900.33

1,917.67

1,926.33

1,943.67

1,952.33

1,969.67

Fibonacci

1,900.33

1,910.27

1,916.40

1,926.33

1,936.27

1,942.40

1,952.33

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Hikma Pharmaceuticals (HIK) Moving Averages

Dec 22, 2024, 06:19 AM

MA5

1,933.80Buy

1,939.82Buy

MA10

1,943.50Buy

1,939.06Buy

MA20

1,945.90Buy

1,931.72Buy

MA50

1,913.06Buy

1,918.91Buy

MA100

1,927.71Buy

1,913.50Buy

MA200

1,901.03Buy

1,898.06Buy

Hikma Pharmaceuticals PLC’s (HIK) 10-Day exponential moving average is 1939.06, while Hikma Pharmaceuticals PLC’s (HIK) share price is 1,952p, making it a Buy.

Hikma Pharmaceuticals PLC’s (HIK) 100-Day exponential moving average is 1913.50, while Hikma Pharmaceuticals PLC’s (HIK) share price is 1,952p, making it a Buy.

Hikma Pharmaceuticals PLC’s (HIK) stock price is 1,952p and Hikma Pharmaceuticals PLC’s (HIK) 50-day simple moving average is 1913.06, creating a Buy signal.

Hikma Pharmaceuticals PLC’s (HIK) stock price is 1,952p and Hikma Pharmaceuticals PLC’s (HIK) 100-day simple moving average is 1927.71, creating a Buy signal.

Hikma Pharmaceuticals PLC’s (HIK) stock price is 1,952p and Hikma Pharmaceuticals PLC’s (HIK) 200-day simple moving average is 1901.03, creating a Buy signal.

Hikma Pharmaceuticals (HIK) Technical Indicators

Dec 22, 2024, 06:19 AM

RSI (14)

56.40

Neutral

STOCH (9,6)

58.27

Neutral

STOCHRSI (14)

58.27

Neutral

MACD (12,26)

10.87

Buy

ADX (14)

16.25

Buy

Williams %R

-31.11

Buy

CCI (14)

-4.60

Neutral

ATR (14)

38.45

Ultimate Oscillator

66.36

Neutral

ROC

0.98

Buy

Hikma Pharmaceuticals PLC’s (HIK) Relative Strength Index (RSI) is 56.40, creating a Neutral signal.

Hikma Pharmaceuticals PLC’s (HIK) Trend Strength Indicator (ADX) is 16.25, creating a Buy signal.

Hikma Pharmaceuticals PLC’s (HIK) Commodity Channel Index (CCI) is -4.60, creating a Neutral signal.

Hikma Pharmaceuticals PLC’s (HIK) Price Rate of Change (ROC) is 0.98, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is HIK a Buy, Hold, or Sell?

Based on HIK’s technical indicators, HIK is a Strong Buy.

What is HIK’s RSI (14)?

HIK’s RSI (14) is 56.40, which suggests HIK is a Neutral.

What is HIK’s MACD?

HIK’s MACD is 10.87, which suggests HIK is a Buy.

What is HIK’s 5-day moving average?

HIK’s 5-day moving average is 1933.80, which suggests HIK is a Buy.

What is HIK’s 20-day moving average?

HIK 20-day moving average is 1945.90, which suggests HIK is a Buy.

What is HIK’s 50-day moving average?

HIK’s 50-day moving average is 1913.06, which suggests HIK is a Buy.

What is HIK’s 200-day moving average?

HIK’s 200-day moving average is 1901.03, which suggests HIK is a Buy.

What is HIK’s Williams % R (14)?

HIK’s Williams % R (14) is -31.11, which suggests HIK is a Buy.

What is HIK’s CCI (14)?

HIK’s CCI (14) is -4.60, which suggests HIK is a Neutral.

What is the share price of Hikma Pharmaceuticals PLC?

Hikma Pharmaceuticals's share price is 1953.00p.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing